Market Tracker

04/29 5:16pm ET

ImmunoCellular Therapeutics Ltd (NYSE MKT LLC:IMUC)

0.255
Delayed Data
As of Apr 29
 -0.015 / -5.56%
Today’s Change
0.20
Today|||52-Week Range
0.64
-28.23%
Year-to-Date
No recent news for ImmunoCellular Therapeutics Ltd.

Today’s Trading

Previous close0.27
Today’s open0.28
Day’s range0.25 - 0.28
Volume311,641
Average volume (3 months)257,123
Market cap$23.4M
Dividend yield--
Data as of 3:59pm ET, 04/29/2016

Growth & Valuation

Earnings growth (last year)+6.25%
Earnings growth (this year)--
Earnings growth (next 5 years)--
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book1.06

Competitors

 Today’s
change
Today’s
% change
--Protea Biosciences G...+0.03+20.00%
ABACAoxin Tianli Group I...-0.02-3.56%
HTGMHTG Molecular Diagno...-0.10-3.51%
OPGNOpGen Inc-0.02-1.26%
Data as of 3:57pm ET, 04/29/2016

Financials

Next reporting dateMay 5, 2016
EPS forecast (this quarter)-$0.07
Annual revenue (last year)$0.00
Annual profit (last year)-$12.8M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Andrew Gengos
Principal Financial &
Accounting Officer
David E. Fractor
Corporate headquarters
Calabasas, California

Forecasts